Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v10-EN
Language French English
Date Updated 2018-06-08 2018-02-21
Drug Identification Number 02231353 02231353
Brand name MYLAN-CYCLOBENZAPRINE MYLAN-CYCLOBENZAPRINE
Common or Proper name Cyclobenzaprine Cyclobenzaprine
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code M03BX M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-20 2018-02-20
Estimated end date Unknown Unknown
Actual end date 2018-06-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments discontinued in ID 51945. Last lot 3044006 exp 31-may-2019
Health Canada comments